Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Dec;29(6):831-5.
doi: 10.1007/s00540-015-2064-2. Epub 2015 Aug 9.

Effect of glycopyrrolate versus atropine coadministered with neostigmine for reversal of rocuronium on postoperative catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor: a prospective randomized study

Hyun-Chang Kim  1 , Sun-Min Lim  2 , Hyungseok Seo  2 , Hee-Pyoung Park  3
Affiliations
Randomized Controlled Trial

Effect of glycopyrrolate versus atropine coadministered with neostigmine for reversal of rocuronium on postoperative catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor: a prospective randomized study

Hyun-Chang Kim et al. J Anesth. 2015 Dec.

Abstract

Background: Muscarinic receptors are involved in the mechanism of postoperative catheter-related bladder discomfort (CRBD). Glycopyrrolate and atropine as adjuncts to reversal of neuromuscular blockers have differential inhibitory effects on muscarinic receptors. This study was conducted to compare the effect of glycopyrrolate versus atropine on postoperative CRBD in patients undergoing transurethral resection of a bladder tumor (TURBT).

Methods: Seventy-four patients undergoing TURBT were randomly allocated to receive either glycopyrrolate 10 μg/kg (glycopyrrolate group, n = 37) or atropine 15 μg/kg (atropine group, n = 37) in combination with neostigmine 25 μg/kg at the end of surgery for reversal of neuromuscular blockade. The incidence and severity (mild/moderate/severe) of CRBD were assessed at 0, 1, 6, and 24 h postoperatively. Tramadol 50-100 mg was administered intravenously if the patients complained of moderate or severe CRBD.

Results: The incidence of CRBD was significantly lower in the glycopyrrolate group than in the atropine group at 0 h (65 % vs. 89 %, p = 0.025) and 1 h (54 % vs. 89 %, p = 0.002) postoperatively. The severity of postoperative CRBD was less severe in the glycopyrrolate group than in the atropine group at 0 h (p = 0.013) and 1 h (p = 0.006). Fewer patients required tramadol in the glycopyrrolate group than in the atropine group (3 % vs. 12 %, p = 0.024).

Conclusions: Glycopyrrolate as an adjunct to reversal of neuromuscular blockers decreased the incidence of early postoperative CRBD and postoperative tramadol requirements in patients undergoing TURBT when compared to atropine.

Trial registration: ClinicalTrials.gov NCT02228473.

Keywords: Atropine; Catheter-related bladder discomfort; Glycopyrrolate; Transurethral resection of bladder tumor.

PubMed Disclaimer

References

    1. J Pharmacol Exp Ther. 2004 Sep;310(3):1255-65 - PubMed
    1. Br J Anaesth. 2006 Jun;96(6):747-53 - PubMed
    1. Anesth Analg. 2007 Nov;105(5):1454-7, table of contents - PubMed
    1. Br J Pharmacol. 1999 May;127(2):413-20 - PubMed
    1. Anesth Analg. 2005 Oct;101(4):1065-7, table of contents - PubMed

Publication types

Associated data

LinkOut - more resources